scholarly journals 592 Using Phenotype and Genomics to Solve Undiagnosed Cardiac Diseases: A Family With Unsolved Conduction Disease and Sudden Cardiac Death

2020 ◽  
Vol 29 ◽  
pp. S304
Author(s):  
F. Stafford ◽  
V. Connell ◽  
N. Nowak ◽  
E. Richardson ◽  
C. Semsarian ◽  
...  
2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
A Kjerrumgaard ◽  
E M Jacobsen ◽  
B L Hansen ◽  
B G Winkel ◽  
A H Christensen ◽  
...  

Abstract Background Guidelines recommend clinical assessment of relatives to young sudden cardiac death (SCD) victims (<50 years) to protect the surviving relatives by pre-symptomatic interventions, in case the SCD was due to an inherited cardiac disorder. The etiology is an inherited cardiac disease in about 50% of young SCD cases. The work-up of relatives is generally guided by findings in the SCD victim. If post-mortem examinations (autopsies) have not been performed the work-up of relatives is challenged. The diagnostic hit-ratio of screening of relatives under these circumstances is unclear. Purpose To assess the diagnostic yield of inherited cardiac diseases of cardiac work-up in relatives of SCD victims, where no autopsy had been performed. Methods This retrospective study consecutively included families referred to our tertiary referral centre, specialised in hereditary cardiac diseases, during the period 2005 to 2018 due to SCD in the family. No autopsy had been performed in any of the SCD victims. The relatives underwent standard cardiac work-up according to guidelines. Based on the findings in the relatives the families were categorised into: 1) definite diagnosis, 2) borderline diagnosis or 3) undiagnosed. Results We assessed 149 relatives (43±16 age, 48% men) to 84 SCD un-autopsied cases (44±11 age, 79% men). In 11 (13%) families a definite diagnosis was established, in 8 (10%) families a borderline diagnosis was found and the remaining 65 (77%) families remained undiagnosed. The most common diagnosis was premature IHD (36%) followed by cardiomyopathies (27%) and channelopathies (27%). A disease-causing mutation was identified in 3 families out of 15 genetically examined families. Conclusion Systematic cardiac work-up of relatives to not-autopsied SCD victims, revealed a definite hereditary cardiac disease in 13% of the referred families, and a borderline diagnosis in additionally 10% of the families. Despite a reduced diagnostic yield in family members of non-autopsied SCD victims, work-up of relatives is clearly still justified.


2006 ◽  
Vol 34 (1) ◽  
pp. 52-57 ◽  
Author(s):  
Elena Ladich ◽  
Renu Virmani ◽  
Allen Burke

Sudden cardiac death (SCD) accounts for approximately 300,000 cardiac events in the United States each year, representing an overall incidence of 0.1–0.2% per year. Although the vast majority of these may be attributed to coronary atherosclerosis, a wide variety of nonatherosclerotic-related cardiac diseases have been associated with SCD. This review highlights three general categories of cardiac disease not related to atherosclerosis: the cardiomyopathies, inflammatory myocardial diseases, and ion channel disorders. The important role played by genetics in some of these cardiovascular diseases is presented as well as toxic and drug-related etiologies.


2008 ◽  
Vol 7 ◽  
pp. 109-109
Author(s):  
R BRECKENRIDGE ◽  
Z ZUBERI ◽  
L FELKIN ◽  
E BIRKS ◽  
P BARTON ◽  
...  

2016 ◽  
Vol 73 (12) ◽  
pp. 759-765
Author(s):  
Bettina Muggli ◽  
Christiane Gruner

Zusammenfassung. Die hypertrophe Kardiomyopathie (HCM) ist die häufigste hereditäre Kardiomyopathie und wird definiert durch eine unerklärte linksventrikuläre Hypertrophie mit normal grossen Ventrikeln ohne andere kardiale Ursachen oder systemische Erkrankungen. Die klinische Präsentation ist vielfältig und reicht vom asymptomatischen Familienmitglied bis hin zu Patienten mit Symptomen einer schweren Herzinsuffizienz. Häufige Probleme sind der plötzliche Herztod (’sudden cardiac death’ SCD) und die Risikostratifizierung der Patienten im Hinblick auf eine primärprophylaktische ICD-Implantation. Des Weiteren spielen natürlich die Obstruktion des linksventrikulären Ausflusstrakts und deren Behandlung (medikamentös, kathetertechnisch mittels Septalalkoholablation, chirugische Myektomie), diastolische Dysfunktion, Vorhofflimmern und die Entwicklung einer Herzinsuffizienz mit systolischer linksventrikulärer Dysfunktion eine wichtige Rolle bei der Betreuung von Patienten mit HCM. Beim Vorhofflimmern muss unabhängig vom CHA2DS2Vasc Score eine orale Antikoagulation begonnen werden und aufgrund der diastolischen Dysfunktion sollte wenn möglich wieder ein Sinusrhythmus erreicht werden durch medikamentöse Massnahmen, elektrische Kardioversion und / oder Pulmonalvenenisolation. Kommt es zur Entwicklung einer Herzinsuffizienz ist eine übliche Herzinsuffizienztherapie indiziert. Bei terminaler Herzinsuffizienz sollte frühzeitig eine Herztransplantation evaluiert werden.


Sign in / Sign up

Export Citation Format

Share Document